Global Diabetes Mortality: Disparities, Rankings & WHO Efforts
This paper examines the global burden of diabetes as a cause of mortality, drawing on World Health Organization data to assess how high blood glucose levels contribute to an estimated 3.7 million deaths annually. It compares regional mortality rates across WHO regions, highlights countries faring better or worse, and situates the United States within the global picture. The paper also surveys the efforts of the WHO Diabetes Programme and the National Diabetes Prevention Program in reducing disease burden, and concludes by analyzing existing disparities in diabetes prevalence and health outcomes across racial, ethnic, age, and gender groups.
- Introduction: The Global Burden of Diabetes: Global diabetes deaths and blood glucose mortality data
- Countries Faring Better or Worse: WHO regional mortality rate comparisons by geography
- How the U.S. Ranks Globally: U.S. diabetes death statistics and national ranking
- WHO and Agency Efforts to Combat Diabetes: WHO programme and National DPP prevention initiatives
- Disparities in Diabetes Prevalence and Outcomes: Racial, age, and gender disparities in diabetes outcomes
- References: Cited sources and bibliography
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Uses specific quantitative data — such as the 3.7 million deaths attributable to high blood glucose and regional mortality figures — to ground abstract claims in concrete evidence.
- Organizes content logically from global scope to national context to programmatic response, giving readers a coherent analytical progression.
- Acknowledges intersecting variables in health disparities, including race, age, and gender, avoiding oversimplification of a complex public health issue.
Key academic technique demonstrated
The paper effectively uses comparative framing — presenting regional, national, racial, and gender-based differences — to show that diabetes is not a uniform experience. By contrasting WHO regional data with U.S.-specific statistics, the author demonstrates how macro-level global trends manifest differently at the national and community level, a technique common in public health writing.
Structure breakdown
The paper opens with global mortality statistics and a clinical definition of diabetes, then moves through a regional WHO comparison, a U.S.-specific section, a policy and agency response section, and closes with a disparities analysis covering race, age, and gender. Each section builds on the previous, creating a layered portrait of the issue from global to local to demographic.
Introduction: The Global Burden of Diabetes
In 2012, 1.5 million lives were lost to diabetes globally. It ranked eighth among the causes of death across both sexes and fifth among women (WHO, 2016). Higher-than-optimal glucose levels — even those that fall below the diabetes diagnostic threshold — are one of the major causes of morbidity and mortality. The diagnostic criterion for diabetes is a fasting plasma glucose level of ≥ 7.0 mmol/L, a threshold chosen because of micro-vascular complications such as diabetic retinopathy. The likelihood of developing a macro-vascular disease such as stroke or heart attack begins to increase even before this threshold is reached (Bellamy, Casas, Hingorani & Williams, 2009).
To comprehend the impact blood glucose levels can have on mortality, one must view blood-glucose-related mortality as a risk factor. The total number of lives lost to high blood glucose in 2012 has been estimated at approximately 3.7 million. This figure includes the 1.5 million deaths directly attributable to diabetes. The remaining 2.2 million deaths are derived from various complications — such as chronic kidney disease, tuberculosis, and cardiovascular diseases — associated with blood glucose levels that are higher than optimal (WHO, 2016).
Create your account
Always verify citation format against your institution’s current style guide requirements.